Article: DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers.
bioRxiv : the preprint server for biology
2023
Abstract: Cancer immune evasion contributes to checkpoint immunotherapy failure in many patients with metastatic cancers. The embryonic transcription factor DUX4 was recently characterized as a suppressor of interferon-γ signaling and antigen presentation that is ... ...
Abstract | Cancer immune evasion contributes to checkpoint immunotherapy failure in many patients with metastatic cancers. The embryonic transcription factor DUX4 was recently characterized as a suppressor of interferon-γ signaling and antigen presentation that is aberrantly expressed in a small subset of primary tumors. Here, we report that |
---|---|
Language | English |
Publishing date | 2023-12-29 |
Publishing country | United States |
Document type | Preprint |
DOI | 10.1101/2023.07.10.548412 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.